Who Will Pay for the COVID-19 Vaccines for Africa?

Don Eliseo Lucero-Prisno III ORCID logo; Isaac OlusholaOgunkola; Uchenna FrankImo; Yusuff AdebayoAdebisi; (2021) Who Will Pay for the COVID-19 Vaccines for Africa? The American journal of tropical medicine and hygiene, 104 (3). pp. 794-796. ISSN 0002-9637 DOI: 10.4269/ajtmh.20-1506
Copy

Africa's health systems are strained by the COVID-19 pandemic. There are global efforts toward the development and trial of COVID-19 vaccines. However, considering the challenges and economic conditions of African nations, there could be limited access and availability of the vaccines on the continent. This will be the result of high cost and technical requirements to acquire the vaccines. There are indications that possible donor funding for COVID-19 vaccines from rich countries maybe put off considering the various challenges they face currently and the moves they are making in response to the disease. The issue of justice in health for protecting the vulnerable populations and regions also supports the need for COVID-19 vaccine availability on the African continent. Means to achieve uniform control of the disease burden across the globe should be adopted. Governments of African nations should also scale up their efforts toward COVID-19 vaccine acquisition and utilization through viable efforts. It is therefore important to assist the African continent in acquiring the COVID-19 vaccines by leveling all power dynamics that will affect access and distribution.



picture_as_pdf
Prisno-etal-2021-Who-will-pay-for-the.pdf
subject
Published Version
Available under Creative Commons: NC 4.0

View Download

Explore Further

Read more research from the creator(s):

Find work associated with the research centre(s):

Find work from this publication: